CLINICAL_TRIALS
trial_result
· 2015-01-16
Clinical Trial Update: Bifeprunox in the Treatment of Schizophrenia [Phase 3]
Summary
The Phase 3 clinical trial evaluating bifeprunox for schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Solvay Pharmaceuticals | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED